Healthcare Industry News: cardiac monitor
News Release - September 19, 2006
Cardiac Science Launches HeartCentrix(TM)Software to Connect Devices With Electronic Medical Record Applications
BOTHELL, Wash., Sept. 19 (HSMN NewsFeed) -- Cardiac Science Corporation (Nasdaq: CSCX ), a global leader in advanced cardiac monitoring and external defibrillation products, announced today that it has launched HeartCentrix, a software solution that enables its diagnostic stress, Holter and electrocardiography devices to communicate seamlessly with physician office-based electronic medical record (EMR) systems.
HeartCentrix enables physicians to maximize their EMR investment by integrating these devices into their workflow. HeartCentrix software is launched from within the EMR, allowing the physician to order a test from within the patient's chart. Once the device performs the test, the physicians can review, edit, and store the results within the EMR application. HeartCentrix also allows physicians to remotely review and confirm test results outside the practice wherever they have internet access to their EMR.
"Physicians continue to select Cardiac Science devices because they trust our brands, and value our technical superiority and product reliability," said Garry Norris, vice president of marketing. "We designed HeartCentrix so that physicians can connect their existing, clinically-trusted devices to their EMRs, creating a simpler workflow for ordering tests and managing data. We believe that HeartCentrix will help physicians provide cardiac care more efficiently and maintain state-of-the-art diagnostic equipment more affordably. We are also very excited by the reception HeartCentrix has received so far from EMR companies."
About Cardiac Science Corporation
Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators, electrocardiographs, stress test systems, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, patient monitor-defibrillators and cardiology data management systems. Cardiac Science also sells a variety of related products and consumables, and provides a comprehensive portfolio of training, maintenance and support services.
The company is the successor to various entities that have owned and operated cardiology-related businesses, which sold products under the trusted brand names Burdick®, Powerheart®, and Quinton®. Cardiac Science is headquartered in Bothell, WA, and also has operations in Lake Forest, California, Deerfield, Wisconsin, Shanghai, China, Copenhagen, Denmark and Manchester, United Kingdom.
This press release contains forward-looking statements. The words "believe," "expect," "intend," anticipate," variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward-looking. Forward looking statements in this press release include those that infer or imply that our HeartCentrix product will be successful in the marketplace, and will facilitate increased sales of our other products, resulting in increasing revenues and profits. These are forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause or contribute to such varying results and other risks are more fully described in the 10-k filed by Cardiac Science Corporation for the year ended December 31, 2005. Cardiac Science Corporation undertakes no duty or obligation to update the information provided herein.
Source: Cardiac Science
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.